<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01361659</url>
  </required_header>
  <id_info>
    <org_study_id>07-2-008</org_study_id>
    <nct_id>NCT01361659</nct_id>
  </id_info>
  <brief_title>Shockwave Treatment for Advanced Angina in Maastricht</brief_title>
  <acronym>SWAAM</acronym>
  <official_title>Shockwave Treatment for Advanced Angina in Maastricht (SWAAM-study).</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maastricht University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medispec ltd.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Maastricht University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      There is an increasing number of patients with a coronary anatomy that does not allow
      additional revascularization procedures, while the patients suffer from angina pectoris at
      rest or at minimal exercise levels despite optimised medical therapy. There is a lack of
      therapeutic options for this group of so called &quot;no-option patients&quot;. Goal of the project is
      to implement the shockwave therapy for no-option coronary artery disease patients and to
      evaluate its potential benefit on regional myocardial perfusion, on regional myocardial
      function and on the potential improvement in symptoms and quality of life.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>May 2007</start_date>
  <completion_date type="Anticipated">December 2012</completion_date>
  <primary_completion_date type="Anticipated">July 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement of exercise tolerance</measure>
    <time_frame>after 6 months</time_frame>
    <description>Modified Bruce protocol, changes compared to the baseline</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Improvement of myocardial perfusion</measure>
    <time_frame>6 months</time_frame>
    <description>myocardial perfusion scintigraphy changes compared to the baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Patients with Adverse Events as a Measure of Safety</measure>
    <time_frame>6 months</time_frame>
    <description>Changes in electrocardiogram and cardiac enzymes (e.g. creatininekinase, troponin), clinical status and chestpain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement of quality of life</measure>
    <time_frame>6 months</time_frame>
    <description>Number of anginal attacks/week, use of nitrates/week</description>
  </secondary_outcome>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Angina</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>shockwave treatment</intervention_name>
    <description>9 treatments in 3 months</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Chronic angina pectoris CCS (Canadian Cardiological Society) III or IV with documented
             reversible ischemia and/or hibernation.

          -  Patients demonstrates exercise tolerance test (ETT) duration &lt; 10 minutes on a
             modified Bruce protocol

          -  No possibility of traditional revascularization by coronary artery bypass grafting
             (CABG) or Percutaneous coronary intervention (PCI)

          -  Patient's conditions stable for at least 3 months

          -  Life expectancy of &gt; 12 months.

        Exclusion Criteria:

          -  Unstable angina pectoris

          -  Haemodynamically significant valvular heart disease

          -  Myocardial infarction &lt;3 month prior randomization

          -  Evidence of intracardiac thrombus

          -  Contraindication for Magnetic resonance imaging (MRI) (pacemaker, metallic prostheses)

          -  Patient is simultaneously participating in another device or drug study, or has
             participated in any clinical trial involving an experimental device or drug, including
             other drugs or devices enhancing cardiac neovascularization or any Extracorporeal
             Shock Wave Therapy (ESWT) machine for neovascularization of a competitor company
             within 3 months of entry into the study.

          -  Patients who are unwilling or unable to cooperate with the study procedure.

          -  Age &lt; 18 years

          -  Cardiac or pulmonary malignancy

          -  No informed consent

          -  Known depression
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>H. Crijns, Prof Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maastricht University Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jindra Vainer, MD</last_name>
    <phone>+31433875106</phone>
    <email>J.Vainer@mumc.nl</email>
  </overall_contact>
  <location>
    <facility>
      <name>Maastricht University Medical Center</name>
      <address>
        <city>Maastricht</city>
        <state>Limburg</state>
        <zip>6229HX</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jindra Vainer, MD</last_name>
      <phone>+31433875106</phone>
      <email>J.Vainer@mumc.nl</email>
    </contact>
    <investigator>
      <last_name>H. Crijns, Prof Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>July 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 12, 2011</study_first_submitted>
  <study_first_submitted_qc>May 26, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 27, 2011</study_first_posted>
  <last_update_submitted>July 11, 2011</last_update_submitted>
  <last_update_submitted_qc>July 11, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 12, 2011</last_update_posted>
  <responsible_party>
    <name_title>Prof Dr Harry Crijns</name_title>
    <organization>Maastricht University Medical Center</organization>
  </responsible_party>
  <keyword>anginal complaints</keyword>
  <keyword>Lithotripsy</keyword>
  <keyword>no option patients</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Angina Pectoris</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

